Mesenchymal stem cells receive adaptive islet–derived miR-151 –containing sEVs to promote β cell compensation in obesity
Science Advances · 2026
DOI: 10.1126/sciadv.adu4196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Xinwei Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Islets of Langerhans, Insulin-Secreting Cells, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiangsu Province Postdoctoral Science Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Pancreatic islets respond to obesity-related insulin resistance by increasing β cell mass and insulin secretion. However, the molecular mechanisms behind this vital compensation are not fully understood. This study shows that adaptive islet–derived small extracellular vesicles (aid-sEVs) play a key role in β cell adaptation in obesity. Aid-sEV production rises under hyperlipidemic conditions, and uptake by adjacent cells occurs via F11R-mediated recognition. Mesenchymal stem cells (MSCs) act as downstream effectors after they internalize aid-sEVs, promoting β cell–adaptive responses. These vesicles deliver miR-151 to MSCs, triggering miR-151– dependent cellular reprogramming toward a Wnt-secreting phenotype. Restoration of miR-151 in microRNA-deficient aid-sEVs restores their proadaptive effects on β cells. Klf9 , a direct target of miR-151 , is involved in regulating MSC proliferation and WNT secretion by controlling Wnt3a and Ccnd1 transcription. These findings reveal a critical pathway controlling β cell compensation in diet-induced obesity and indicate that targeted enhancement of aid-sEV secretion could be a therapeutic strategy to counteract β cell dysfunction in diabetic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, Jiangsu, China.
- Department of Endocrinology, Geriatric Hospital of Nanjing Medical University, 30 Luojia Road, Nanjing, Jiangsu, China.
- School of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
ORCID-Profile: Xinwei Guo, Yang Wang, Ruixue Du, Wei Yong, Wenjing Yan, Zicheng Zhang, Yi Pan, Yanfeng Zhang, Yumeng Shen, Yue Yang, Fangfang Zhang, Jianxing Liu, Wei Tang, Yue Liu, Liang Jin
Förderung
- Jiangsu Province Postdoctoral Science Foundation
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Jiangsu Province Youth Science and Technology Talent Support Program
- Double First Class University
- Xinjiang Production and Construction Corps Natural Science Fund
- Shihezi University Carthamus Tinctorius Industry Research Institute Open Project
Zitieren
APA
Guo, X., Wang, Y., Du, R., Yong, W., Yan, W., Zhang, Z., Pan, Y., Zhang, Y., Shen, Y., Yang, Y., Zhang, F., Liu, J., Tang, W., Liu, Y., & Jin, L. (2026). Mesenchymal stem cells receive adaptive islet–derived miR-151 –containing sEVs to promote β cell compensation in obesity. Science Advances. https://doi.org/10.1126/sciadv.adu4196
Vancouver
Guo X, Wang Y, Du R, Yong W, Yan W, Zhang Z, et al. Mesenchymal stem cells receive adaptive islet–derived miR-151 –containing sEVs to promote β cell compensation in obesity. Science Advances. 2026. doi:10.1126/sciadv.adu4196
BibTeX
@article{Guo2026,
author = {Guo, Xinwei and Wang, Yang and Du, Ruixue and Yong, Wei and Yan, Wenjing and Zhang, Zicheng and Pan, Yi and Zhang, Yanfeng and Shen, Yumeng and Yang, Yue and Zhang, Fangfang and Liu, Jianxing and Tang, Wei and Liu, Yue and Jin, Liang},
title = {Mesenchymal stem cells receive adaptive islet–derived miR-151 –containing sEVs to promote β cell compensation in obesity},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adu4196}
}
EUVIMED